败血症
全身炎症
炎症
发病机制
平衡(能力)
抗菌剂
医学
结果(博弈论)
免疫学
生物
微生物学
经济
物理疗法
数理经济学
作者
Rachel Brandes-Leibovitz,Anca Riza,Gal Yankovitz,Andrei Pîrvu,Stefania Dorobantu,Adina Dragos,Ioana Streață,Isis Ricaño-Ponce,Aline de Nooijer,Florentina Dumitrescu,Nikolaos Antonakos,Eleni Antoniadou,George Dimοpoulos,Ioannis Koutsodimitropoulos,Theano Kontopoulou,Dimitra Markopoulou,E. Aimoniotou,Apostolos Komnos,George N. Dalekos,Mihai Ioana,Evangelos J. Giamarellos-Bourboulis,Irit Gat‐Viks,Mihai G. Netea
标识
DOI:10.1016/j.xcrm.2024.101829
摘要
Patients with sepsis differ in their clinical presentations and immune dysregulation in response to infection, but the fundamental processes that determine this heterogeneity remain elusive. Here, we aim to understand which types of immune dysregulation characterize patients with sepsis. To that end, we investigate sepsis pathogenesis in the context of two transcriptional states: one represents the immune response to eliminate pathogens (resistance, R) and the other is associated with systemic inflammation (SI). We find that patients with sepsis share a molecular fingerprint of a low R-to-SI balance-i.e., a low R relative to the level of SI. Differences between patients with sepsis are explained by the wide diversity of R and SI states that fall under this fingerprint, such as patients with high SI, patients with low R, or both. We show how this R/SI framework can be used to guide patient stratification that is relevant to disease prognosis and management, outperforming existing classifications of sepsis.
科研通智能强力驱动
Strongly Powered by AbleSci AI